跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS
Approved
STANDARD
AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2024
Approval ID
87131efc9ad2d4f2
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
87131efc9ad2d4f2
Drug Cima Aemps Name
AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS
Register Number
LT120001224001IP
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2024-11-11
Dosage Form
COMPRIMIDO RECUBIERTO
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
EXEMESTANO
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2024
Approval ID
87131efc9ad2d4f2
Type
Standard
Back to CIMA-AEMPS Approvals
AROMASIL 25 mg COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details